vs

Side-by-side financial comparison of LANDSTAR SYSTEM INC (LSTR) and Solventum (SOLV). Click either name above to swap in a different company.

Solventum is the larger business by last-quarter revenue ($2.0B vs $1.2B, roughly 1.7× LANDSTAR SYSTEM INC). LANDSTAR SYSTEM INC runs the higher net margin — 3.4% vs 3.2%, a 0.2% gap on every dollar of revenue. On growth, LANDSTAR SYSTEM INC posted the faster year-over-year revenue change (1.6% vs -3.7%). Over the past eight quarters, Solventum's revenue compounded faster (-0.4% CAGR vs -2.2%).

Landstar System, Inc. is an American transportation services company specializing in logistics and, more specifically, third-party logistics. Landstar utilizes an extensive network of over 8,800 independent owner-operators, referred to internally as business capacity owners (BCOs), over 1,000 independent freight agents, and over 70,000 vetted carriers. Landstar provides services principally throughout the United States and to a lesser extent in Canada and between the U.S. and Canada, Mexico, ...

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

LSTR vs SOLV — Head-to-Head

Bigger by revenue
SOLV
SOLV
1.7× larger
SOLV
$2.0B
$1.2B
LSTR
Growing faster (revenue YoY)
LSTR
LSTR
+5.3% gap
LSTR
1.6%
-3.7%
SOLV
Higher net margin
LSTR
LSTR
0.2% more per $
LSTR
3.4%
3.2%
SOLV
Faster 2-yr revenue CAGR
SOLV
SOLV
Annualised
SOLV
-0.4%
-2.2%
LSTR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LSTR
LSTR
SOLV
SOLV
Revenue
$1.2B
$2.0B
Net Profit
$39.4M
$63.0M
Gross Margin
9.6%
51.4%
Operating Margin
4.5%
6.3%
Net Margin
3.4%
3.2%
Revenue YoY
1.6%
-3.7%
Net Profit YoY
32.3%
103.2%
EPS (diluted)
$1.16
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSTR
LSTR
SOLV
SOLV
Q1 26
$1.2B
Q4 25
$1.2B
$2.0B
Q3 25
$1.2B
$2.1B
Q2 25
$1.2B
$2.2B
Q1 25
$1.2B
$2.1B
Q4 24
$1.2B
$2.1B
Q3 24
$1.2B
$2.1B
Q2 24
$1.2B
$2.1B
Net Profit
LSTR
LSTR
SOLV
SOLV
Q1 26
$39.4M
Q4 25
$23.9M
$63.0M
Q3 25
$19.4M
$1.3B
Q2 25
$41.9M
$90.0M
Q1 25
$29.8M
$137.0M
Q4 24
$46.2M
$31.0M
Q3 24
$50.0M
$122.0M
Q2 24
$52.6M
$89.0M
Gross Margin
LSTR
LSTR
SOLV
SOLV
Q1 26
9.6%
Q4 25
51.4%
Q3 25
54.2%
Q2 25
54.4%
Q1 25
53.8%
Q4 24
53.9%
Q3 24
56.0%
Q2 24
54.6%
Operating Margin
LSTR
LSTR
SOLV
SOLV
Q1 26
4.5%
Q4 25
2.5%
6.3%
Q3 25
2.2%
80.6%
Q2 25
4.6%
9.9%
Q1 25
3.4%
7.3%
Q4 24
4.8%
6.6%
Q3 24
5.2%
13.2%
Q2 24
5.6%
11.7%
Net Margin
LSTR
LSTR
SOLV
SOLV
Q1 26
3.4%
Q4 25
2.0%
3.2%
Q3 25
1.6%
60.4%
Q2 25
3.5%
4.2%
Q1 25
2.6%
6.6%
Q4 24
3.8%
1.5%
Q3 24
4.1%
5.9%
Q2 24
4.3%
4.3%
EPS (diluted)
LSTR
LSTR
SOLV
SOLV
Q1 26
$1.16
Q4 25
$0.70
$0.37
Q3 25
$0.56
$7.22
Q2 25
$1.20
$0.51
Q1 25
$0.85
$0.78
Q4 24
$1.30
$0.18
Q3 24
$1.41
$0.70
Q2 24
$1.48
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSTR
LSTR
SOLV
SOLV
Cash + ST InvestmentsLiquidity on hand
$411.0M
$878.0M
Total DebtLower is stronger
$26.1M
$5.0B
Stockholders' EquityBook value
$799.0M
$5.0B
Total Assets
$1.6B
$14.3B
Debt / EquityLower = less leverage
0.03×
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSTR
LSTR
SOLV
SOLV
Q1 26
$411.0M
Q4 25
$452.2M
$878.0M
Q3 25
$434.4M
$1.6B
Q2 25
$426.2M
$492.0M
Q1 25
$473.4M
$534.0M
Q4 24
$566.6M
$762.0M
Q3 24
$531.3M
$772.0M
Q2 24
$504.0M
$897.0M
Total Debt
LSTR
LSTR
SOLV
SOLV
Q1 26
$26.1M
Q4 25
$0
$5.0B
Q3 25
$0
$5.1B
Q2 25
$0
$7.8B
Q1 25
$0
$7.9B
Q4 24
$0
$8.0B
Q3 24
$0
$8.1B
Q2 24
$0
$8.3B
Stockholders' Equity
LSTR
LSTR
SOLV
SOLV
Q1 26
$799.0M
Q4 25
$795.7M
$5.0B
Q3 25
$888.7M
$5.0B
Q2 25
$921.8M
$3.6B
Q1 25
$930.8M
$3.3B
Q4 24
$972.4M
$3.0B
Q3 24
$1.0B
$3.2B
Q2 24
$1.0B
$2.9B
Total Assets
LSTR
LSTR
SOLV
SOLV
Q1 26
$1.6B
Q4 25
$1.6B
$14.3B
Q3 25
$1.7B
$14.0B
Q2 25
$1.7B
$15.1B
Q1 25
$1.7B
$14.5B
Q4 24
$1.8B
$14.5B
Q3 24
$1.8B
$14.7B
Q2 24
$1.8B
$14.6B
Debt / Equity
LSTR
LSTR
SOLV
SOLV
Q1 26
0.03×
Q4 25
0.00×
1.00×
Q3 25
0.00×
1.03×
Q2 25
0.00×
2.14×
Q1 25
0.00×
2.43×
Q4 24
0.00×
2.71×
Q3 24
0.00×
2.54×
Q2 24
0.00×
2.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSTR
LSTR
SOLV
SOLV
Operating Cash FlowLast quarter
$95.0M
Free Cash FlowOCF − Capex
$32.0M
FCF MarginFCF / Revenue
1.6%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$-10.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSTR
LSTR
SOLV
SOLV
Q1 26
Q4 25
$72.7M
$95.0M
Q3 25
$89.3M
$76.0M
Q2 25
$7.1M
$169.0M
Q1 25
$55.7M
$29.0M
Q4 24
$61.1M
$219.0M
Q3 24
$83.1M
$169.0M
Q2 24
$48.1M
$355.0M
Free Cash Flow
LSTR
LSTR
SOLV
SOLV
Q1 26
Q4 25
$70.5M
$32.0M
Q3 25
$86.0M
$-21.0M
Q2 25
$4.7M
$59.0M
Q1 25
$53.8M
$-80.0M
Q4 24
$54.4M
$92.0M
Q3 24
$75.6M
$76.0M
Q2 24
$40.6M
$297.0M
FCF Margin
LSTR
LSTR
SOLV
SOLV
Q1 26
Q4 25
6.0%
1.6%
Q3 25
7.1%
-1.0%
Q2 25
0.4%
2.7%
Q1 25
4.7%
-3.9%
Q4 24
4.5%
4.4%
Q3 24
6.2%
3.7%
Q2 24
3.3%
14.3%
Capex Intensity
LSTR
LSTR
SOLV
SOLV
Q1 26
Q4 25
0.2%
3.2%
Q3 25
0.3%
4.6%
Q2 25
0.2%
5.1%
Q1 25
0.2%
5.3%
Q4 24
0.6%
6.1%
Q3 24
0.6%
4.5%
Q2 24
0.6%
2.8%
Cash Conversion
LSTR
LSTR
SOLV
SOLV
Q1 26
Q4 25
3.04×
1.51×
Q3 25
4.61×
0.06×
Q2 25
0.17×
1.88×
Q1 25
1.87×
0.21×
Q4 24
1.32×
7.06×
Q3 24
1.66×
1.39×
Q2 24
0.91×
3.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LSTR
LSTR

Segment breakdown not available.

SOLV
SOLV

Infection Prevention And Surgical Solutions$752.0M38%
Cost Of Software And Rentals$508.0M25%
Health Information Systems Segment$347.0M17%
Dental Solutions Segment$343.0M17%
Related Party$14.0M1%

Related Comparisons